Abstract

Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call